Update on Measles Mortality Reduction Activities and Linkages with RI.

Slides:



Advertisements
Similar presentations
Global Measles and Rubella Strategic Plan
Advertisements

1 June 2011 Measles update- India Dr. Satish Kumar Gupta Health Specialist UNICEF- India 13 th September 2011.
Immunization Services DR. KANUPRIYA CHATURVEDI DR.S.K. CHATURVEDI.
Review Meeting with State Health Secretaries on 11 th & 12 th September, Integrated Disease Surveillance Programme (IDSP)
1 Dr. Azhar Abid Raza Washington Sept 2011 Measles elimination in Pakistan.
NPSP – Structure and Function
Pentavalent vaccine Introduction in UIP in India:
Monitoring progress towards the coverage and disease incidence targets GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING March 2011 Geneva, Switzerland.
Measles and Rubella Elimination in the WHO European Region: Update on Progress & Challenges Global Measles and Rubella Management Meeting March 2011.
Measles outbreak investigation & Response Jordan DR MOHAMAD RATIB SUROUR NATIONAL EPI MANAGER INTER-COUNTRY MEETING ON MEASLES AND RUBELLA CONTROL AND.
The Cape Verde experience with rubella outbreak & lessons from introducing rubella vaccines MoH Cape Verde ARCI meeting Dar es Salaam, Tanzania Dec 2012.
A global partnership to stop measles & rubella The Measles & Rubella Initiative: Preparing for the Next Decade Lisa Cairns, MD, MPH Sept 18, 2012 Washington,
Proceedings of the SAGE Working Group on Rubella Vaccines Susan E. Reef, MD Global Measles and Rubella Management Meeting March 15, 2011.
Supporting Routine AND Supplementary Immunization Activities in STOP.
Plan of Action to improve injection Safety Within the EPI.
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
Routine Immunization: The Missed Child Perspective Maya van den Ent, PharmD MPH Edward Hoekstra, MD, MSc David Brown, DSc, MScPH, MSc Halima Dao, MD, MSc.
INTEGRATED DISEASE SURVEILLANCE PROJECT( IDSP)
RNTCP: DOTS Expansion and plans for DOTS-Plus
Polio eradication programme in India – Progress, Response and Issues for action Dr Ajay Khera Deputy Commissioner Ministry of Health & FW, Govt. of India.
Routine Immunization: R ecent initiatives and progress in high risk areas 23 rd India Expert Advisory Group July, 2011 Dr Pradeep Haldar, MoHFW,
Improving Health System and Strengthening NRHM through Community Action Experiences, Lessons Learnt, Challenges and Way Forward AGCA Secretariat Population.
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.
Emergency Preparedness and Response Plan Dr. Ajay Khera Deputy Commissioner Ministry of Health & FW, Government of India.
1 1 Measles elimination and rubella control in the SEA Region- a brief Update 12 th Annual Meeting of the Measles Rubella Initiative (MRI) September,
1 | Global Immunization Meeting: PIA Sitges, June 2015 New tools and strategies for maternal and neonatal tetanus and measles/rubella elimination.
Immunization service delivery – immunization management prospective.
Role of Schools - in Implementation of Measles catch-up campaigns
IMMUNIZATION IN UGANDA Dan Wamanya IMMUNIZATION IN UGANDA Dan Wamanya USAID/Uganda.
Microplanning for Routine Immunization
Update on the Implementation of Measles 2 nd Dose in India Ms. Anuradha Gupta Joint Secretary, Ministry of Health Govt. of India Global Measles and Rubella.
Measles in EMR 7 th Annual Meeting of Partners for Measles Advocacy Washington, 2007.
MEASLES MORTALITY REDUCTION IN INDIA Status and Future Plans.
Progress of Polio Eradication in India, Current Risks & Actions taken on last IEAG report 24 th IEAG, New Delhi 15 March 2012 Dr. Ajay Khera Deputy Commissioner.
The Challenge of Getting Vaccines Delivered and Used Robert Steinglass Technical Director IMMUNIZATIONbasics JSI Research & Training Institute Discovery,
JAHSR TECHNICAL REVIEW MEETING EPI Report Dr Dafrossa C Lyimo Programme Manager 7th September 2010 Dar es salaam.
Initiatives to improve UIP including convergence with polio activities Dr. Pradeep Haldar 24 th Meeting of IEAG March, 2012.
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
World Health Organization Eastern Mediterranean Region.
Funding Update: 2013 – 2015 September 10,
Measles pre-elimination in the African Region. Presentation to the MI 10 th annual meeting Sept 2011 B Masresha WHO AFRO.
Global Overview of Measles & Rubella 11 th Annual Meeting The Measles Initiative Washington, DC th September, 2012.
1 |1 | Measles pre-elimination and resurgence in the African region Balcha Masresha IVD AFRO Global Measles Management Meeting Geneva March 2011.
Tackling child malnutrition the LAGAAN approach S B Agnihotri 15/01/2015.
India: Transitioning of Polio Network to Support Other Immunization Activities Jeffrey W McFarland, MD Regional Advisor, WHO South-East Asia Regional Office.
Improving Coverage of Newborn Vaccinations in India
Situation overview and Meeting Objectives The Middle East Polio Outbreak Phase II Review.
Supplementary Immunization Activities Quality, Coverage of high risk populations/ areas, proposed plans for IEAG Meeting 15 March 2011.
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
Update on Progress toward Measles Situation in EMR September 2008 Dr B. Naouri VPI/DCD/EMRO.
Poliovirus Surveillance and Risks to Polio Eradication in India Dr. Hamid Jafari WHO-NPSP.
Poliovirus Surveillance status of quality, actions to improve sensitivity WHO-India 15 March 2012.
Measles Mortality Reduction: the risk of resurgence Global Immunization Meeting Geneva, Switzerland 1-3 February 2010 Balcha Masresha, WHO/AFRO.
2015 Measles & Rubella Initiative Annual Partners Meeting, Human & Financial Costs of Measles and Rubella, 15 September 2015, Washington, DC Achieving.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
Sustaining the gains and reaching milestones on the way towards elimination of measles and rubella 15 September 2015 Dr Peter Strebel, WHO, IVB/EPI.
New Vaccine Introduction ‘MR vaccine introduction in Kenya’
PROGRESS TOWARDS MEASLES & RUBELLA ELIMINATION EXPERIENCE FROM OMAN SALAH AL AWAIDY, MD COMMUNICABLE DISEASES ADVISOR MOH, OMAN
World Health Organization Western Pacific Regional Office Expanded Programme on Immunization Measles Elimination in the Western Pacific Region 2007 Partners.
Global Measles and Rubella: Highlights, Priorities and Critical Issues
Global Overview of Measles
Measles Rubella surveillance in India
Module 8 CD-JEV immunization campaigns
23 November, 2018 Update on measles & rubella surveillance in the WHO African Region – progress and challenges Dr Richard Luce WHO/IST-Central 5th African.
Stakeholder Consultation
Saturating prevention coverage through complementary programming.
World Health Organization
STRATEGIES AND PROGRESS
Developing a Financial Sustainability Plan for Cambodia
Presentation transcript:

Update on Measles Mortality Reduction Activities and Linkages with RI

Presentation outline Global context Update on accelerated measles control – MCV-2 in Routine services – Catch-up campaigns – Laboratory supported measles surveillance Linkages with RI Summary and way forward

Principles of accelerated measles control strategies in India 1.Improve and sustain routine immunization coverage (MCV-1) 2.Provide a second opportunity for measles immunization to all eligible children (MCV-2) 3.Sensitive, laboratory supported measles outbreak surveillance for case/outbreak confirmation 4.Fully investigate all detected measles outbreaks and ensure appropriate case management

Global Context: Worldwide measles vaccination delivery strategies, mid-2010 MCV1 & MCV2, no SIAs (40 member states or 21%) MCV1 & regular SIAs (59 member states or 31%) MCV1, MCV2 & one-time catch-up (36 member states or 19%) MCV1, MCV2 & regular SIAs (57 member states or 28%)

Presentation outline Global context Update on accelerated measles control – MCV-2 in Routine services – Catch-up campaigns – Laboratory supported measles surveillance Linkages with RI Summary and way forward

SIA: MCV1 <80% RI: MCV1 > 80% 2 nd Dose of Measles vaccine: State specific delivery strategies MCV1: Coverage of Measles containing vaccine per DLHS-3; CES-06 for Nagaland

MCV2 introduction through Supplementary Immunization Activity (SIA) in Phases  Initiated in November 2010; Gujarat will finish in coming weeks  45 districts from 13 states o9 district from Chhattisgarh o5 districts from each of the 6 states (Bihar, Jharkhand, Rajasthan, Madhya Pradesh, Gujarat & Haryana) o1 district from each of the 6 North-East states  Approximately 14 million target children 9 months – 10 yrs Phase 1

Coverage achieved: Administrative and RCA monitoring 11,963,663 of 13,845,686 vaccinated (86.4%) 18 of 45 districts with >= 90% coverage (40%) Data as on 12 July 2011

Un-aware of need (43.9%) Reasons for unvaccinated children: RCA surveys results IEC/IPC (43.7%) Operational Gap (3.7%) N=unvaccinated children; 30,200 Note: Figures are % of total responses provided

Selected session quality indicators % session site with adequate vaccine & syringes97.4% % sites where diluents kept cool before reconstitution98.4% % sites where time of reconstitution written on vial93.5% % sites where reconstituted vials kept in the hole of 1 icepack97.4% % sites where sterile part of syringe remained untouched95.4% % sites where vaccinators following ‘no recapping’89.4% % sites where vaccinators know what to do in case of a serious AEFI93.2% % sites having functional hub cutter87.6% % sites where supervisor visited once in a day75.4% n=22,343 n=campaign vaccination sessions were monitored

Enhanced AEFI surveillance during the Measles catch-up campaigns  304 minor AEFIs and 40 serious AEFIs reported  All serious AEFIs reported and correctly managed  NO DEATHS – VACCINE OR PROGRAMME RELATED

Experiences from 1 st Phase: Areas for improvement Coordination and planning: – Better coordination of the three primary department of Health, Education and ICDS – Clear timelines of availability of logistics Communication and advocacy: – IEC,BCC and interpersonal communication – IAP, IMA and private doctors sensitization – Private school principals orientation Vaccination in urban areas Injection waste management Supervision at all levels

Measles SIA plan, India Phase 2 A (144 districts) Phase 1, 45 districts covered Phase 2 B (81 districts) Phase 3 (91 districts) Target Population: 126,127,387 Target vaccine doses: 136,217,578

Planned phases of measles catch-up campaigns Phase 1Phase 2APhase 2BPhase 3Total DatesQ – Q Q3 – Q Q1 2012Q No. districts Target population (9m-10yrs) millions Children vaccinated (millions) 12.0

Objectives of Measles Surveillance India is in mortality reduction phase: – Surveillance should reliably detect areas of transmission (not every case) – Investigate larger outbreaks – Estimate CFR – Identify under-immunized pockets for RI strengthening – Inform policy decisions related to susceptible age groups to guide supplemental immunization activities

Expansion of laboratory supported measles outbreak surveillance, based on Polio-network Reporting of clinical measles cases linked with AFP weekly reporting in these states Weekly aggregate data should be mutually shared with IDSP One state level lab strengthened in each state testing for measles and rubella IgM

Total cases = 9,221 Vaccinated Not Vaccinated Unknown * Serologically and epidemiologically confirmed cases ** Data from 8 states (Andhra Pradesh, Gujarat, Karnataka, Kerala, Madhya Pradesh, Rajasthan, Tamilnadu and West Bengal * data as on 15 th Jun, 2011  61 % no or unknown vaccination status  86 % < 10 yrs of age Serologically confirmed measles outbreaks: Age and vaccination status of measles cases*, 2011

Serologically confirmed # measles, rubella and mixed outbreaks (Andhra Pradesh, Gujarat, Karnataka, Kerala, Madhya Pradesh, Rajasthan, Tamil Nadu and West Bengal) 129 outbreaks Measles outbreaks confirmed Rubella outbreaks confirmed Mixed outbreaks confirmed * # Outbreak confirmation for Measles: 2011 ≥ 2 cases IgM positive for measles and rubella * data as on 15 th Jun, # outbreaks Widespread measles virus transmission indicating gaps in RI

Presentation outline Global context Update on accelerated measles control – MCV-2 in Routine services – Catch-up campaigns – Laboratory supported measles surveillance Linkages with RI Summary and way forward

RI – Measles synergies Measles catch-up campaigns has helped, RI – By augmenting AEFI surveillance (reporting & management) – By improving injection safety practices on a large scale – By enforcing waste management practices (as per CPCB) – By optimizing cold-chain space & efficient vaccine stock management practice at various levels (state/district/block) – Encouraging fixed-day, fixed-site session based approach RI-Measles Synergy study is being done in Jharkhand

Presentation outline Global context Update on accelerated measles control – MCV-2 in Routine services – Catch-up campaigns – Laboratory supported measles surveillance Linkages with RI Summary and way forward

Finalize post-measles campaign coverage evaluation surveys in Bihar and Jharkhand to validate administrative coverage. Preparation and planning has been initiated for Phase 2 catch-up campaigns – Revision of Operational Guidelines and vaccinator training modules – National planning workshop / ToT for state program managers planned in August 2011 and to be followed by State ToTs – State planning/ ToT workshops to document 1 st phase experience and carry forward lessons learnt to 2 nd phase Expansion of laboratory supported measles outbreak surveillance in coordination with IDSP to document virus transmission following the campaigns

Thank you